Evidence·Exposure / Absorption
ReportedCmax evidence
ATLXM0054285
A single reference-linked measurement — its measured value, assay/model context, and interpretation layer kept separate.
Stack
ATLXM0054285
A single reference-linked measurement — its measured value, assay/model context, and interpretation layer kept separate.
ATLXM0054285
After subcutaneous single dose administrations, C max and AUC of liraglutide increased proportionally over the therapeutic dose range of 0.6 mg to 1.8 mg.
This page treats the row as evidence attached to an endpoint and assay context. The layer describes how the row can be interpreted; it is not a safety or developability score by itself.
